v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Total revenue $ 12,455 $ 8,615 $ 21,181 $ 16,804
Operating expenses:        
Cost of sales 1,702 1,495 2,787 2,122
Research and development 91,940 77,401 164,683 146,021
Selling, general and administrative 45,869 35,536 87,396 66,550
Total operating expenses 139,511 114,432 254,866 214,693
Loss from operations (127,056) (105,817) (233,685) (197,889)
Interest income, net 14,513 8,120 30,600 17,009
Other income, net 523 1,579 1,776 3,213
Net loss $ (112,020) $ (96,118) $ (201,309) $ (177,667)
Net income (loss) per share - basic (in usd per share) $ (1.93) $ (1.69) $ (3.49) $ (3.14)
Net income (loss) per share - diluted (in usd per share) $ (1.93) $ (1.69) $ (3.49) $ (3.14)
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares) 57,932,576 56,802,546 57,697,193 56,593,011
Weighted-average number of common shares used in computing net income (loss) per share – diluted (in shares) 57,932,576 56,802,546 57,697,193 56,593,011
Product revenue, net        
Revenues:        
Total revenue $ 12,455 $ 8,615 $ 21,181 $ 16,804